Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) shares gapped down before the market opened on Monday. The stock had previously closed at $40.23, but opened at $38.29. Carl Zeiss Meditec shares last traded at $38.21, with a volume of 212 shares traded.
Wall Street Analyst Weigh In
A number of research analysts recently commented on the company. UBS Group downgraded Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research note on Tuesday, August 11th. Zacks Research upgraded shares of Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research note on Tuesday, October 6th. The Goldman Sachs Group lowered shares of Carl Zeiss Meditec from a “hold” rating to a “sell” rating in a report on Monday, October 5th. Finally, Morgan Stanley assumed coverage on shares of Carl Zeiss Meditec in a research report on Wednesday, September 2nd. They issued an “underweight” rating for the company. Two analysts have rated the stock with a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Strong Sell”.
Read Our Latest Stock Analysis on Carl Zeiss Meditec
Carl Zeiss Meditec Price Performance
The business’s 50-day simple moving average is $36.64 and its two-hundred day simple moving average is $32.88.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG is a medical technology company headquartered in Jena, Germany, and part of the ZEISS Group. The company develops, manufactures and distributes equipment and solutions for ophthalmology and microsurgery, serving hospitals, clinics and medical professionals worldwide.
Its ophthalmic portfolio includes diagnostic systems for examining the eye, equipment for cataract and refractive surgery, surgical lasers, intraocular lenses and other related products. The company also supplies surgical microscopes, visualization systems and digital technologies used in neurosurgery, spine surgery, ear, nose and throat procedures, and other microsurgical specialties.
Carl Zeiss Meditec was established in 2002 through the combination of the ophthalmic activities of Carl Zeiss and Asclepion-Meditec.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
